au.\*:("TINEL M")
Results 1 to 25 of 36
Selection :
FORMATION OF INACTIVE CYTOCHROME P-450 FE(II)-METABOLITE COMPLEXES WITH SEVERAL ERYTHROMYCIN DERIVATIVES BUT NOT WITH JOSAMYCIN AND MIDECAMYCIN IN RATSLARREY D; TINEL M; PESSAYRE D et al.1983; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1983; VOL. 32; NO 9; PP. 1487-1493; BIBL. 27 REF.Article
Soins infirmiers en réanimation lors de l'oxygénothérapie humidifiée à haut débit = Nursing in the intensive care unit in relation to humidified high-flow oxygen therapyTIGREAT, J; KOLAKOWSKI, A; TINEL, M.-E et al.Réanimation (Paris. 2001). 2012, Vol 21, Num 6, pp 731-738, issn 1624-0693, 8 p.Article
Methoxsalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in micaLETTERON, P; DEGOTT, C; LABBE, G et al.Toxicology and applied pharmacology. 1987, Vol 91, Num 2, pp 266-273, issn 0041-008XArticle
Metabolic activation of the tricyclic antidepressant amineptine. I: Cytochrome P-450-mediated in vitro covalent bindingGENEVE, J; LARREY, D; LETTERON, P et al.Biochemical pharmacology. 1987, Vol 36, Num 3, pp 323-329, issn 0006-2952Article
Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin : comparison with erythromycin and roxithromycinFISHER, D; LABBE, G; BERSON, A et al.The Journal of pharmacology and experimental therapeutics. 1990, Vol 254, Num 3, pp 1120-1127, issn 0022-3565, 8 p.Article
Metabolic activation of the new tricyclic antidepressant tianeptine by huam liver cytochrome P450LARREY, D; TINEL, M; LETTERON, P et al.Biochemical pharmacology. 1990, Vol 40, Num 3, pp 545-550, issn 0006-2952, 6 p.Article
Inhibitory effects of nilutamide, a new androgen receptor antagonist, on mouse and human liver cytochrome P-450BABANY, G; TINEL, M; LETTERON, P et al.Biochemical pharmacology. 1989, Vol 38, Num 6, pp 941-947, issn 0006-2952Article
Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in miceLETTERON, P; DESCATOIRE, V; LARREY, D et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 239, Num 2, pp 559-567, issn 0022-3565Article
Extensive oxidative metabolism of dextromethorphan in patients with almitrine neuropathyBELEC, L; LARREY, D; DE CREMOUX, H et al.British journal of clinical pharmacology. 1989, Vol 27, Num 3, pp 387-390, issn 0306-5251Article
Nilutamide inhibits mephenytoin 4-hydroxylation in untreated male rats and in human liver microsomesHORSMANS, Y; LANNES, D; LARREY, D et al.Xenobiotica (London. Print). 1991, Vol 21, Num 12, pp 1559-1570, issn 0049-8254Article
Differences in hepatic drug accumulation and enzyme induction after chronic amiodarone feeding of two rat strains: role of the hydroxylator phenotype?PIROVINO, M; HONEGGER, U; MÜLLER, O et al.British journal of pharmacology. 1990, Vol 99, Num 1, pp 35-40, issn 0007-1188Article
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolidesTINEL, M; DESCATOIRE, V; LARREY, D et al.The Journal of pharmacology and experimental therapeutics. 1989, Vol 250, Num 2, pp 746-751, issn 0022-3565Article
Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamstersLARREY, D; TINEL, M; LETTERON, P et al.Biochemical pharmacology. 1986, Vol 35, Num 13, pp 2213-2220, issn 0006-2952Article
Mechanism for isaxonine hepatitis. I: Metabolic activation by mouse and human cytochrome P-450LETTERON, P; FOUIN-FORTUNET, H; TINEL, M et al.The Journal of pharmacology and experimental therapeutics. 1984, Vol 229, Num 3, pp 845-850, issn 0022-3565Article
Mechanism for isaxonine hepatitis. II: Protective role of glutathione and toxicological studies in miceFOUIN-FORTUNET, H; LETTERON, P; TINEL, M et al.The Journal of pharmacology and experimental therapeutics. 1984, Vol 229, Num 3, pp 851-858, issn 0022-3565Article
Polymorphism of dextromethorphan oxidation in a French populationLARREY, D; AMOUYAL, G; TINEL, M et al.British journal of clinical pharmacology. 1987, Vol 24, Num 5, pp 676-679, issn 0306-5251Article
Inactivation and induction of cytochrome P-450 by various psoralen derivatives in ratsLETTERON, P; DESCATOIRE, V; LARREY, D et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 238, Num 2, pp 685-692, issn 0022-3565Article
Protective effect of 16,16-dimethyl prostaglandin E2 on the hepatotoxicity of bromobenzene in miceFUNCK-BRENTANO, C; TINEL, M; DEGOTT, C et al.Biochemical pharmacology. 1984, Vol 33, Num 1, pp 89-96, issn 0006-2952Article
Effects of pregnancy on the toxicity and metabolism of acetaminophen in miceLARREY, D; LETTERON, P; FOLIOT, A et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 237, Num 1, pp 283-291, issn 0022-3565Article
Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the ratTHAL, C; KAHWAJI, J. E; LOEPER, J et al.The Journal of pharmacology and experimental therapeutics. 1994, Vol 268, Num 1, pp 515-521, issn 0022-3565Article
Metabolic activation of the antidepressant tianeptine. I: Cytochrome P-450-mediated in vitro covalent bindingLETTERON, P; DESCATOIRE, V; TINEL, M et al.Biochemical pharmacology. 1989, Vol 38, Num 19, pp 3241-3246, issn 0006-2952Article
Metabolic activation of the tricyclic antidepressant amineptine. II: Protective role of glutathione against in vitro and in vivo covalent bindingGENEVE, J; DEGOTT, C; LETTERON, P et al.Biochemical pharmacology. 1987, Vol 36, Num 3, pp 331-337, issn 0006-2952Article
Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patientsLARREY, D; BABANY, G; TINEL, M et al.British journal of clinical pharmacology. 1989, Vol 28, Num 3, pp 297-304, issn 0306-5251Article
